Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1978-2-23
|
pubmed:abstractText |
Tumor-specific immunity mediated by thymus-derived lymphocytes (T cells) was established in C3H/He mice against syngeneic X5563 plasmacytoma. Splenic T cells from mice, which exhibited resistance to tumor challenge, revealed a potent in vivo tumor-neutralizing activity as well as in vitro cytotoxicity. In contrast, spleen cells from mice 7 days after tumor cell inoculation (7-day tumor-bearing mice) exhibited no protective activity when assayed by in vivo tumor-neutralization test, whereas these cells exhibited almost comparable in vitro cytotoxic activity to that from the tumor-resistant mice. Any suppressor cell activity was not detected in 7-day tumor-bearing animals. While a slight in vivo protective activity was observed in the spleen cells from 14-day tumor-bearing mice, this activity was still significantly weaker than that of spleen cells from mice similarly inoculated with tumor 14 days before but whose tumor had been removed 7 days before the assay. The development of in vivo protective immunity in tumor-resected mice was suppressed by intravenous inoculation with 7000 R X-irradiated tumor cells. These results indicate that in vitro reactivity of immune T lymphocyte population is not always correlated with in vivo protective immunity, but there is a substantial decrease in in vivo immune capability of T cells from tumor-bearing animals, and that this suppression may be ascribed to the presence of a large amount of tumor-associated transplantation antigens rather than to suppressor cell activity.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0016-450X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
68
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
589-601
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:73490-Animals,
pubmed-meshheading:73490-Antigens, Neoplasm,
pubmed-meshheading:73490-Cytotoxicity, Immunologic,
pubmed-meshheading:73490-Epitopes,
pubmed-meshheading:73490-Female,
pubmed-meshheading:73490-Immunity, Cellular,
pubmed-meshheading:73490-Immunologic Memory,
pubmed-meshheading:73490-Lymphocyte Depletion,
pubmed-meshheading:73490-Male,
pubmed-meshheading:73490-Mammary Neoplasms, Experimental,
pubmed-meshheading:73490-Mice,
pubmed-meshheading:73490-Mice, Inbred C3H,
pubmed-meshheading:73490-Neoplasms, Experimental,
pubmed-meshheading:73490-Plasmacytoma,
pubmed-meshheading:73490-Spleen,
pubmed-meshheading:73490-T-Lymphocytes,
pubmed-meshheading:73490-Time Factors
|
pubmed:year |
1977
|
pubmed:articleTitle |
Inhibitory effect of tumor-bearing state on the generation of in vivo protective immune T cells in a syngeneic murine tumor system.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
In Vitro
|